Earnings Per Share, Basic of DMK PHARMACEUTICALS Corp from 31 Mar 2013 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
DMK PHARMACEUTICALS Corp quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Mar 2013 to 30 Sep 2023.
  • DMK PHARMACEUTICALS Corp Earnings Per Share, Basic for the quarter ending 30 Sep 2023 was -0.2, a 90% increase year-over-year.
  • DMK PHARMACEUTICALS Corp Earnings Per Share, Basic for the twelve months ending 30 Sep 2023 was 2.
  • DMK PHARMACEUTICALS Corp annual Earnings Per Share, Basic for 2022 was -0.18, a 44% increase from 2021.
  • DMK PHARMACEUTICALS Corp annual Earnings Per Share, Basic for 2021 was -0.32.
  • DMK PHARMACEUTICALS Corp annual Earnings Per Share, Basic for 2016 was -1.19, a 17% decline from 2015.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

DMK PHARMACEUTICALS Corp Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 2 -0.2 +1.85 +90% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 0 -3.4 +0.52 +13% 01 Apr 2023 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 0 -0.06 +0.01 +14% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 0 5.86 +5.92 01 Oct 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
Q3 2022 -6 -2.05 -1.97 -2462% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 -4 -3.92 -3.86 -6433% 01 Apr 2022 30 Jun 2022 10-Q 21 Aug 2023 2023 Q2
Q1 2022 0 -0.07 +0.05 +42% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 0 -0.06 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 -0.08 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 -0.06 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 -0.12 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2016 -1 0.07 +0.35 01 Oct 2016 31 Dec 2016 10-K 30 Mar 2017 2016 FY
Q3 2016 -2 -0.41 -0.18 -78% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 -1 -0.37 -0.1 -37% 01 Apr 2016 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 -1 -0.48 -0.24 -100% 01 Jan 2016 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 -1 -0.28 +0.13 +32% 01 Oct 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q3 2015 -1 -0.23 -0.03 -15% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 -1 -0.27 0 0% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 -1 -0.24 -0.09 -60% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q1
Q4 2014 -1 -0.41 01 Oct 2014 31 Dec 2014 10-K 23 Mar 2016 2015 FY
Q3 2014 -0.2 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q2 2014 -0.27 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 -0.15 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1

DMK PHARMACEUTICALS Corp Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 -0.18 +0.14 +44% 01 Jan 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
2021 -0.32 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2016 -1.19 -0.17 -17% 01 Jan 2016 31 Dec 2016 10-K 30 Mar 2017 2016 FY
2015 -1.02 +0.01 +0.97% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 -1.03 +0.08 +7.2% 01 Jan 2014 31 Dec 2014 10-K 23 Mar 2016 2015 FY
2013 -1.11 +0.12 +9.8% 01 Apr 2013 31 Mar 2014 10-KT 26 Mar 2015 2014 FY
2012 -1.23 01 Apr 2012 31 Mar 2013 10-K 23 Jun 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.